Items Tagged ‘biomarkers’
January 30, 2020
A breakthrough in distinguishing benign adrenal tumors from cancerous ones
By Advancing the Science contributor 
By Christoph Bahn Approximately 80 million CT scans are performed in the United States every year. Adrenal tumors are found incidentally in about 5% of these scans. Most of these tumors will turn out to be benign, but a small fraction will be adrenal cortical carcinoma, a type of cancer with high mortality and frequent recurrence; even for […]
Tags: adrenal tumors, biomarkers, biopsy, cancer, clinical research, CT, endocrine cancer, endocrinology, epidemiology, hormones, Irina Bancos, Mayo Clinic Laboratories
July 10, 2019
Biomarkers could help early diagnosis of Alzheimer’s
By Advancing the Science contributor
Early diagnosis will ultimately be essential in the management and treatment of Alzheimer’s disease. Examination of Alzheimer’s biomarkers can improve the prediction of short-term memory decline in middle-age and elderly individuals, according to new research led by Mayo Clinic.
Tags: Alzheimer's disease, biomarkers, Clifford Jack Jr., Mayo Clinic Study of Aging, Rochester Epidemiology Project
April 3, 2019
Research News Roundup-March 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Removal of ‘zombie cells’ alleviates causes of diabetes in obese mice Mayo Clinic researchers and their collaborators have shown that when senescent […]
Tags: AFib, aging, Alzheimer's disease, atrial fibrillation, biomarkers, cancer, Center for the Science of Health Care Delivery, clinical trials, diabetes, gastroenterology, hepatitis, liver disease
February 5, 2019
Research News Roundup-January 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research-related news releases from Mayo Clinic in the past month. It also connects readers to associated resources. Read on for more information from Mayo Clinic Research. Minnesota Partnership awards 5 collaborative research grants Diabetes, stress-induced aging and Alzheimer’s disease, immigration-related obesity, and implantable drug […]
Tags: artificial intelligence, basic science, biomarkers, cancer, cervical cancer, clinical trials, concussion, heart failure, James Kirkland, Kathy MacLaughlin, Kogod Center on Aging, Mayo Clinic Proceedings
November 8, 2018
MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question
By Advancing the Science contributor
In 2017, Mayo Clinic launched a first-in-the-U.S. clinical test to help patients with some autoimmune disorders get the right diagnosis faster. The test defines a new form of inflammatory demyelinating disease, myelin oligodendrocyte glycoprotein (MOG) autoimmunity, which is distinct from multiple sclerosis (MS), with which it is commonly confused. The test uses live cells to […]
Tags: acute flaccid myelitis, Andrew McKeon, biomarkers, Department of Laboratory Medicine and Pathology, MOG antibody, multiple sclerosis, neuroimmunology, neurology, Sean Pittock, transverse myelitis, Vanda Lennon
July 19, 2018
A clearer picture: new imaging technologies advance diagnosis, individualized care
New imaging technologies are advancing diagnosis and individualizing care. Imaging tests – such as a CT scan or MRI – are essential tools that health care providers use to answer complex and challenging questions. Gabriel Krestin, M.D., Ph.D., a radiologist and researcher, is at the forefront of new efforts to apply cutting edge imaging technologies […]
Tags: biomarkers, Center for Individualized Medicine, individualized medicine, Individualizing Medicine Conference, Kiaran McGee, radiology
November 2, 2017
Targeting a Molecular Abnormality
Microsatellite instability (MSI) might sound like something a NASA engineer would study. But it’s actually a molecular abnormality found in 15 percent of colorectal cancers, explains Mayo Clinic medical oncologist and gastroenterologist Frank A. Sinicrope, M.D., who is testing an immunotherapy drug that could help patients with this subtype of colorectal cancer. Just recently, researchers […]
Tags: biomarkers, clinical trials, Forefront, Mayo Clinic Cancer Center
March 15, 2016
New Treatment-Sequencing Based on Biomarker Elevation in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of death in men and women and is projected to increase to the second leading cause of death by 2020 if there are not significant treatment advances made. Our current understanding of pancreatic cancer suggests that it is a systemic disease in most patients, meaning, that by the time of […]
Tags: biomarkers, Center for the Science of Health Care Delivery, Elizabeth Habermann, John (Jay) Bergquist, Mark Truty, pancreatic cancer, surgery, surgical outcomes